Nanoviricides NNVC
NYSE NNVC
$1.47 -0.01 (-1.01%)
As of: Oct 21, 2026 · 11:38 AM EDT

Nanoviricides (NNVC) Receivables - Other (2014)

Updated

Nanoviricides (NNVC) recorded Receivables - Other of $110,578 in fiscal Q1 2015 (quarter ended Sep 30, 2014), down 97.8% from the prior quarter.

Analysis

Nanoviricides (NNVC) Receivables - Other (2014) Analysis & Trends

At the end of FY2014 (ended Jun 30, 2014), Nanoviricides reported Receivables - Other of $5.03 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Nanoviricides 29.68 Mn 17.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 110,578.00
Jun 30, 2014 5.03 Mn
API Access

Nanoviricides Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=NNVC&period=max&api_key=YOUR_API_KEY